HAEMOLYTIC ANAEMIA AS A COMPLICATION OF INTRAVENOUS IMMUNOGLOBULIN THERAPY. Issue 12 (15th November 2016)

• Record Type: Journal Article
• Authors: Salam, Sharfaraz; Woodall, Amanda; Gosal, David
• Is Part Of: Journal of neurology, neurosurgery and psychiatry. Volume 87:Issue 12(2016)
• Page Start: e1
• Page End: e1
• Publication Date: 2016-11-15
• Subjects: Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Psychiatry -- Periodicals; 616.8
• DOI: 10.1136/jnnp-2016-315106.187
• Languages: English
• ISSNs: 0022-3050

Abstract

Abstract : Aim: To monitor a series of thirty consecutive patients receiving their first dose of intravenous immunoglobulin for haemolytic anaemia. Methods: Prospectively, thirty consecutive patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) receiving their first high dose of immunoglobulin therapy were monitored for clinical and laboratory features of haemolytic anaemia. Results: Three patients were identified with features suggestive for haemolysis. Conclusion: We confirm the literature findings of a strong association between high dose intravenous immunoglobulin therapy and haemolysis in neurology patients receiving immunoglobulin therapy.